Search Results 1061-1070 of 19957 for Receptor
... receptor (e.g., CTLA-4, OX 40, CD137); any other checkpoint inhibitor; bevacizumab; or any prior vaccine therapy. Note: Other inclusion and exclusion ...
The researchers measured nucleocapsid and spike protein S1 receptor-binding domain-specific immunoglobulin G antibodies in sera after participants completed the ...
Updated results from a phase 1 study (CRB-401) of idecabtagene vicleucel (ide-cel, bb2121), an anti-B cell maturation antigen (BCMA) chimeric antigen receptor ...
Angiotensin-converting enzyme inhibitors, also called ACE inhibitors, and angiotensin II receptor blockers, also called ARBs. These medicines relax blood ...
Cabozantinib S-malate is a chemotherapy drug known as a tyrosine kinase inhibitor, and it targets specific tyrosine kinase receptors, that when blocked, may ...
... receptor blocker (ARB) or calcium channel blocker (CCB). third line agent including one of the above and/or direct vasodilator, such as hydralazine or ...
Positive promyelocytic leukemia/retinoic acid receptor PML/RAR alpha by polymerase chain reaction (PCR). Patients must accept treatment and supportive care ...
“We tested Toll-like receptor (TLR) agonists — drugs that mimic invasive bacteria — as a strategy to trick the immune system into attacking cancer as if it ...
Endoxifen, an estrogen receptor targeted therapy: From bench to bedside. Endocrinology. 2021; doi:10.1210/endocr/bqab191. Goetz MP, et al. Tumor sequencing ...
Chimeric antigen receptor (CAR)-T cell therapy trains the immune system ... The receptors help the cells recognize a marker on the surface of the lymphoma cells.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.